Fenofibrate and Risedronate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Risedronate sodium (risedronate sodium). Common drug interactions include influenza among females and c-reactive protein increased among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Risedronate sodium. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Risedronate sodium?

Risedronate sodium has active ingredients of risedronate sodium. It is often used in osteoporosis. eHealthMe is studying from 14,019 Risedronate sodium users. Check the latest studies of Risedronate sodium.

On Jul, 07, 2026

46 people who take Fenofibrate and Risedronate sodium together, and have interactions are studied.

Fenofibrate and Risedronate sodium drug interactions.

What are the common drug interactions of Fenofibrate and Risedronate Sodium, by gender? *:

female:

Influenza
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Insomnia (sleeplessness)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Ligament sprain (ligament stretched)
Lipase increased
Lumbar radiculopathy (radicular pain in the low back and legs)
Macule (a discoloured spot on the skin)
Migraine (headache)

male:

C-reactive protein increased
Fatigue (feeling of tiredness)
Defaecation urgency (a sudden compelling urge to defecate)
Drug ineffective
Erythema (redness of the skin)
Extravasation blood (leakage of blood from a vessel into tissues)
Haemorrhage (bleeding)
Herpes zoster
Pyrexia (fever)
Skin discolouration (change of skin colour)

What are the common drug interactions of Fenofibrate and Risedronate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood glucose increased
Chills (felling of cold)
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Inflammation
Joint stiffness
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)

50-59:

Weight decreased
Blood amylase increased
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Chronic hepatitis (long lasting inflammation of liver)
Dizziness
Fall
Fatigue (feeling of tiredness)
Foot fracture
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Ligament sprain (ligament stretched)

60+:

Fatigue (feeling of tiredness)
Atrioventricular block (heart block)
Cardiac failure
Drug eruption (adverse drug reaction of the skin)
Hypertension (high blood pressure)
Impaired driving ability
Red blood cell sedimentation rate increased
Sinoatrial block
Synovitis (inflammation of the synovial membrane)
Diarrhoea

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 26.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 8.70%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.52%
High Blood Pressure: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Risedronate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously